Merck & Co., Inc.MRKNYSE
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank72
Year-over-Year Change
Year-over-year operating income growth rate
Latest
33.29%
↓ 46% vs avg
Percentile
P72
Within normal range
Streak
2 qtr
Consecutive growthRecovering
Average
61.75%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 33.29% |
| Q3 2025 | 18.05% |
| Q2 2025 | -6.48% |
| Q1 2025 | 36.55% |
| Q4 2024 | 9.14% |
| Q3 2024 | -34.99% |
| Q2 2024 | 6.39% |
| Q1 2024 | 436.25% |
| Q4 2023 | -129.17% |
| Q3 2023 | 217.16% |
| Q2 2023 | -231.69% |
| Q1 2023 | 9.15% |
| Q4 2022 | -15.08% |
| Q3 2022 | -18.97% |
| Q2 2022 | -9.87% |
| Q1 2022 | 49.96% |
| Q4 2021 | -23.85% |
| Q3 2021 | 190.27% |
| Q2 2021 | -40.05% |
| Q1 2021 | 245.82% |
| Q4 2020 | -177.38% |
| Q3 2020 | 2.91% |
| Q2 2020 | -38.81% |
| Q1 2020 | 44.13% |
| Q4 2019 | 5.66% |
| Q3 2019 | -24.41% |
| Q2 2019 | 1.47% |
| Q1 2019 | 19.50% |
| Q4 2018 | 7.06% |
| Q3 2018 | 17.56% |
| Q2 2018 | 97.21% |
| Q1 2018 | -46.98% |
| Q4 2017 | 1384.25% |
| Q3 2017 | -94.23% |
| Q2 2017 | 21.56% |
| Q1 2017 | 553.81% |
| Q4 2016 | -114.95% |
| Q3 2016 | 85.27% |
| Q2 2016 | -6.01% |
| Q1 2016 | -9.68% |